Background Currently, no effective measures are available to predict the curative efficacy of
small-cell lung cancer (SCLC) chemotherapy. We expect to develop a method for effectively …

Early diagnosis is vital to improving the survival rate of patients with small-cell lung cancer
(SCLC). Considering recent applications of mass spectrometry (MS) to cancer research, this …

Aim Detection of novel tumor biomarker will aid in diagnosis of early-stage small cell lung
cancer (SCLC). The purpose of this study was to identify novel tumor biomarker in serum …

The aim of this study was to identify serum protein fingerprints of small cell lung cancer
(SCLC) and potential biomarkers related to chemotherapy resistance of SCLC with surface …

Currently, no satisfactory biomarkers are available to screen for small‐cell lung cancer
(SCLC). We applied a surface‐enhanced laser desorption/ionization time‐of‐flight mass …

Background Only a minority of patients with advanced non-small cell lung cancer (NSCLC)
benefit from chemotherapy. Serum peptide profiling of NSCLC patients was performed to …

8007 Background: A limited number of patients with advanced stage non-small cell lung
cancer (NSCLC) respond to chemotherapy. Serum peptide profiling of patients treated with …

Background The purpose of this study is to discover potential biomarkers in serum for the
detection of small cell lung cancer (SCLC). Methods 74 serum samples including 30 from …

Aim To identify discriminating protein patterns in serum samples among non‐small cell lung
cancer (NSCLC), chronic obstructive pulmonary disease (COPD), pneumonia, and healthy …

Purpose We validated a previously reported proteomic signature, associated with treatment
outcome, in an independent cohort of patients with non‐small cell lung cancer (NSCLC). A …